Jim Kling is a professional freelance science and medical writer. He contributes to publications such as Medscape and MDEdge, covering topics including neurology, cancer treatments, and women's health. With a background in both science and writing, Jim brings a unique perspective to his articles, providing readers with valuable insights into the latest developments in the medical field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jim Kling's coverage primarily focuses on healthcare and pharmaceutical topics, with an emphasis on scientific research. He frequently cites data in his articles, indicating a preference for evidence-based information.
To effectively reach out to Jim Kling, consider providing him with access to recent and relevant scientific studies or clinical trial data related to the topics he covers. Experts who can interpret complex medical data and provide insightful analysis would likely be valued sources for his articles.
Given the specificity of his article titles, pitching new developments in neurology, myasthenia gravis treatments, breast cancer therapies or advancements in artificial intelligence within these medical fields could capture Jim Kling's interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Article Targeted Therapies in Oncology November I, 2024 Volume 13
Researchers have identified separate gut bacteria species that can metabolize purines and urate, suggesting that microbial pathways might be leveraged through probiotics to reduce hyperuricemia.
SAN DIEGO—An artificial intelligence machine learning algorithm applied to imaging data successfully identified patients with metabolic dysfunction–associated steatotic liver disease who likely would have otherwise been missed, according to new data presented at TLM 2024.
In patients with MASLD, bariatric surgery was associated with a lower risk for mortality than medical management.
Black lung disease and silicosis have roots in the industrial revolution, and beryllium disease dates to before World War II, but these conditions have not been consigned to the dustbin of history.
Efforts to combat hyperuricemia may find help from gut microbes, according to Dylan Dodd, MD, PhD, who spoke at the annual research symposium of the Gout, Hyperuricemia, and Crystal-Associated Disease Network.
Individuals on a Mediterranean-inspired diet had good outcomes, but concerns remain about long-term compliance.
Redundancies in gout remission criteria from 2016 led to a vote at a meeting of the Gout Hyperuricemia and Crystal-Associated Disease Network for newly refined criteria for remission.
By: Jim Kling
In a nearly unanimous vote at the annual research symposium of the Gout Hyperuricemia and Crystal-Associated Disease Network ( G-CAN ), members
A Mediterranean-inspired plant-based diet improved self-reported measures of gout as well as uric acid levels, a pilot study has found.
(833) 317-6278 
